You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-Bromodomain-BRD9-IN-28
BRD9-IN-28

Chemical Structure : BRD9-IN-28

CAS No.: 1947372-67-9

BRD9-IN-28

Catalog No.: PC-62938Not For Human Use, Lab Use Only.

BRD9-IN-28 is a highly potent and selective BRD7/9 bromodomain inhibitor with pIC50 of 6.9, Kd of 68 nM for BRD9.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    BRD9-IN-28 is a highly potent and selective BRD7/9 bromodomain inhibitor with pIC50 of 6.9, Kd of 68 nM for BRD9.
    BRD9-IN-28 is slightly less potent against BRD7 (Kd=368 nM) and completely inactive against BAZ2B, little affinity across BRD proteins from sub-families 1-3 and 5-8, including BAZ2A and BAZ2B.
    BRD9-IN-28 shows weak affinity for the BRDs from CBP, p300 and FALZ.

    Physicochemical Properties

    M.Wt 360.417
    Formula C21H20N4O2
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    1-(1-(imidazo[1,2-a]pyridin-5-yl)-7-morpholinoindolizin-3-yl)ethan-1-one

    References

    1. Duncan. A. Hay, et al. Med. Chem. Commun., 2015, DOI: 10.1039/C5MD00152H.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: